Vaccinex Expands Access to ActivMAb Antigen Virus Technology
ActivMAb's new "Antigen Virus" application complements drug discovery strategies for complex protein targets, according to Vaccinex CEO. Ongoing partnerships can ...
- Latest
- Trending
ActivMAb's new "Antigen Virus" application complements drug discovery strategies for complex protein targets, according to Vaccinex CEO. Ongoing partnerships can ...
China Medical University Hospital (CMUH) is partnering with Google Cloud to use generative AI for cancer care. The AI can ...
Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
A study warns that declining air quality in the US could cost companies and employees billions by 2050s. Climate change ...
Diversity in biotechnology and venture capital is crucial for driving innovation and breakthroughs in healthcare, according to Dr. Stanley Lewis. ...
Efforts to diversify biotech venture capital funding could lead to innovation, breakthroughs in healthcare, and improved outcomes for minorities.
AGI, the next phase in AI evolution, aims to replicate human-like intelligence. It could revolutionize sectors like eldercare and reshape ...
The weight-loss drugs of Eli Lilly and Novo Nordisk have led to soaring share prices as investors anticipate high demand ...
Insilico Medicine and University of Toronto collaborate to target "undruggable" cancer genes using AI-designed molecules. AI is revolutionizing drug discovery ...
Biotech company Vaccinex, Inc. plans a reverse stock split to meet Nasdaq's minimum bid price requirement and retain its listing. ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.